Charter Research, LLC

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Alzheimer disease3 trials
• Mild cognitive impairment1 trial

Phase

• Phase 32 trials
• Phase 21 trial

Status

• Active, not recruiting1 trial
• Suspended1 trial
• Terminated1 trial

Lead sponsor

• Biogen2 trials
• Green Valley (Shanghai) Pharmaceuticals Co., Ltd.1 trial

Running trials

• Active, not recruiting

  A Study to Learn About the Safety of Diranersen (BIIB080) Injections and Whether They Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD Dementia Between 50 to 80 Years of Age

  NCT05399888· Phase 2· Biogen· Source

Closed trials

• Terminated

  A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease

  NCT05310071· Phase 3· Biogen· Source